A major new clinical study has found that a type of immunotherapy may help stop a rare and fast-growing skin cancer from spreading to other parts of the body. The drug, pembrolizumab (brand name KEYTRUDA), was tested in patients with Merkel cell carcinoma, a rare but aggressive form of skin cancer. The trial, called STAMP [.] The post New drug may help prevent spread of deadly skin cancer appeared first on Knowridge Science Report.